Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Autor: Xing, Ligang, Wu, Gang, Wang, Luhua, Li, Jiancheng, Wang, Jianhua, Yuan, Zhiyong, Chen, Ming, Xu, Yaping, Fu, Xiaolong , Zhu, Zhengfei, Lu, You, Han, Chun, Xia, Tingyi, Xie, Conghua, Li, Guang, Ma, Shenglin, Lu, Bing, Lin, Qin, Zhu, Guangying, Qu, Baolin, Zhu, Wanqi, Yu, Jinming
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 April 2021 109(5):1349-1358
Databáze: ScienceDirect